Natural Cycles Wins FDA Clearance for Fertility Algorithm

Natural Cycles is showing how a regulated digital-health product can keep changing its core algorithm after launch.

What happened

The company received FDA 510(k) clearance for a next-generation fertility algorithm using statistical modelling and machine learning to personalise predictions.

It is Natural Cycles’ sixth FDA clearance. The updated system analyses user data to estimate fertile and non-fertile days while adapting predictions to the individual cycle.

Why it matters

In consumer software, an algorithm can be updated continuously. A medical device has to show that a material change remains safe and effective within a regulated framework.

The clearance demonstrates a repeatable pathway for improving software-based health products rather than freezing them at the version originally approved.

The bigger picture

Digital health increasingly sits between consumer apps and clinical devices. Regulation can build trust, but clearance does not remove the need for careful real-world monitoring, clear user instructions and evidence across diverse populations. The detailed performance claims released with the update are company-provided and should be assessed alongside independent evidence as it becomes available.